August 23, 2016
(San Diego Union-Tribune) – But amid this torrent of discoveries, there’s a growing backlog in trying to put them into action. The innovations remain stuck in the laboratories or kept within elite medical institutions, left untranslated into medications, equipment and other therapies that would help doctors, health insurers and the public. Fixing the bottleneck has become its own branch of medical science. The young but exploding field is known by various names that emphasize various nuances — translational medicine, personalized medicine, individualized medicine and precision medicine.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.